Article
Author(s):
Contrave is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults.
Medication Pearl of the Day: Naltrexone HCl and Bupropion HCl (Contrave)
Indication: Contrave is a combination of naltrexone, an opioid antagonist, and bupropion, an aminoketone antidepressant, indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) in the presence of at least 1 weight-related comorbidity (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).
Insight:
Reference: LABEL (fda.gov)
FDA Approves Ustekinumab-kfce as Sixth Biosimilar to Stelara